Is it still worthwhile to treat bone metastases from differentiated thyroid carcinoma with radioactive iodine?

1992 ◽  
Vol 16 (4) ◽  
pp. 640-645 ◽  
Author(s):  
C. A. G. Proye ◽  
D. H. R. Dromer ◽  
B. M. Carnaille ◽  
A. J. P. Gontier ◽  
A. Goropoulos ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Bone Metastases ◽  
Radioactive Iodine ◽  
Differentiated Thyroid Carcinoma

131J-speichernde pulmonale und ossäre Metastasen differenzierter Schilddrüsenkarzinome bei niedrigem Serum-Thyreoglobulinspiegel – Ausnahme in der Tumornachsorge?

1987 ◽  
Vol 26 (03) ◽  
pp. 139-142 ◽  
Author(s):  
G. Arning ◽  
O. Schober ◽  
H. Hundeshagen ◽  
Ch. Ehrenheim
Keyword(s):  
Serum Level ◽  
Thyroid Carcinoma ◽  
Bone Metastases ◽  
Differentiated Thyroid Carcinoma ◽  
Serum Thyroglobulin ◽  
Thyroglobulin Level ◽  
Low Serum

In the follow-up of differentiated thyroid carcinoma it is discussed whether the tumormarker thyroglobulin can replace the1311 scan, especially when the thyroglobulin serum level is normal. A positive1311 scan of metastases in the follow-up of patients with differentiated thyroid carcinoma combined with a low serum thyroglobulin level is extremely rare. The literature shows a frequency of about 4%. Recently we found 3 cases with a positive1311 scan demonstrating pulmonary and bone metastases whereas the serum thyroglobulin level was low.

scholarly journals Diagnosis and Management of Thyroid Cancer

1995 ◽  
Vol 2 (2) ◽  
pp. 107327489500200
Author(s):  
Christopher L. Alexander ◽  
Roberto E. Izquierdo ◽  
James Figge ◽  
John Horton
Keyword(s):  
Thyroid Carcinoma ◽  
Radioactive Iodine ◽  
Imaging Techniques ◽  
Needle Aspiration ◽  
Differentiated Thyroid Carcinoma ◽  
The Past ◽  
Locally Recurrent ◽  
Improvement In Survival ◽  
Radioactive Iodine Ablation ◽  
Radionuclide Scanning

Thyroid carcinoma, which comprises the majority of endocrine malignancies, has a substantial annual morbidity and mortality based on age and other predisposing factors. Diagnosis of a growing thyroid nodule can be difficult, but ultrasonography, radionuclide scanning, and fine needle aspiration allow the majority of nodules to be properly characterized. Treatment of differentiated thyroid carcinoma remains controversial. Surgical resection continues to be the most important modality with long survival if the tumor is resected early. Newer imaging techniques have improved the diagnosis of locally recurrent or metastatic disease. Radioactive iodine ablation is indicated for patients with “high-risk” tumors or advanced age. Few patients respond to cytotoxic chemotherapy. In the past decade, advances in the screening and diagnosis of medullary thyroid carcinoma have led to earlier detection with improvement in survival.

Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma

Thyroid ◽  
2016 ◽  
Vol 26 (11) ◽  
pp. 1623-1629 ◽  
Author(s):  
Rafael Selbach Scheffel ◽  
André B. Zanella ◽  
José Miguel Dora ◽  
Ana Luiza Maia
Keyword(s):  
Thyroid Carcinoma ◽  
Radioactive Iodine ◽  
Differentiated Thyroid Carcinoma

Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in Korea

Thyroid ◽  
2020 ◽  
Vol 30 (5) ◽  
pp. 732-738 ◽  
Author(s):  
Eyun Song ◽  
Mijin Kim ◽  
Eui Young Kim ◽  
Bo Hyun Kim ◽  
Dong Yeob Shin ◽  
...  
Keyword(s):  
Thyroid Carcinoma ◽  
Multicenter Study ◽  
Radioactive Iodine ◽  
Differentiated Thyroid Carcinoma
Sign in / Sign up

Export Citation Format

Share Document